Agenda

Sigourney Bonner, Ph.D., CEO, Co-founder Black in Cancer

Doug Lowy, M.D., Principal Deputy Director, National Cancer Institute

John Carpten, Ph.D., Director, City of Hope

Panel moderated by Kaylin Carey, Morehouse School of Medicine

• Ethan Dmitrovsky, M.D., Frederick National Laboratory for Cancer Research
• Kimberly Jeffries Leonard, Ph.D., American Cancer Society
• Clayton Yates, Ph.D., Johns Hopkins University

Panel moderated by Mamadou Bah, BIC Mentorships.

• Lucile Adams-Campbell, Ph.D., Georgetown University
• Carla Williams, Ph.D., Howard University Cancer Center
• Madison Moore, Ph.D., MD Anderson Cancer Center

• American Cancer Society
• National Cancer Institute Networking
• FDA Career Panel/Science Communications
• Fred Hutch
• Frederick National Laboratory for Cancer Research

• 1-1:05 p.m: Mike Oliphant, Harvard University
• 1:05-1:10 p.m: Hannah Simba, World Health Organization
• 1:10-1:15 p.m: Diandra Vaval Taylor, University of Illinois Chicago

• 1:15-1:35 p.m: Jelani Zarif, Ph.D., Cancer Moonshot Scholar, Johns Hopkins University
• 1:35-1:55 p.m: Paula Hammond, Ph.D., BIC Fellow, Massachusetts Institute of Technology Koch Institute
• 1:55-2:15 p.m: "The Blood-Brain Barrier: New Perspectives on Drug Delivery in Malignant Gliomas," Sadhana Jackson, Ph.D., National Institutes of Health
• 2:15-2:35 p.m: "Novel Nanotechnology Platform for HER2-Positive Breast Cancer Treatment," Emmanuel Akala, R. Ph., Ph.D., Professor of Pharmaceutics, Howard University

• 2:50-3:10 p.m: "Harnessing pyroptosis for cancer immunotherapy," Cornelius Taabazuuing, Ph.D., University of Pennsylvania
• 3:10-3:30 p.m: Kandice Tanner, Ph.D., NCI Center for Cancer Research
• 3:30-3:50 p.m: "The Role of Ferroptosis in Shaping the Tumor Microenvironment: Implications for Cancer Treatment," Whitney Henry, Ph.D., Massachusetts Institute of Technology

Panel moderated by Chanelle Case Borden, Ph.D., NCI Center for Cancer Training.

• Ellie Daniels, M.D., M.P.H., American Cancer Society
• Erica Bozeman, Ph.D., Johnson & Johnson
• Willie May, Ph.D., Morgan State University, AAAS Chair

Laronna S. Colbert, M.D.

Elshaddai White, Ph.D., Black in Cancer.

Otis Brawley, M.D., Johns Hopkins University

Kimryn Rathmell, M.D., Ph.D., Director, National Cancer Institute

Melissa Davis, Ph.D., Morehouse School of Medicine

• 10:15-10:35 a.m: Ricki Fairley, Touch BBCA
• 10:35-10:55 a.m: Clayton Yates, Ph.D., Johns Hopkins University
• 10:55-11:15 a.m: Kirk Taylor, M.D., Brainstorm Cell Therapeutics
• 11:15-11:35 a.m: Barry Gause, M.D., Frederick National Laboratory for Cancer Research

Chad Womack, VP of STEM Initiatives, United Negro College Fund

• Cancer Research UK
• National Cancer Institute Networking
• Industry Career Panel
• Bristol Myers Squibb
• Frederick National Laboratory for Cancer Research

Moderator: Sherry Hughes, Cincinnati Cancer Advisors

• 1:15-1:35 p.m: Monica Baskin, PhD, UPMC Hillman Cancer Center
• 1:35-1:55 p.m: Taofeek Owonikoko, M.D., Ph.D., University of Maryland Greenebaum Comprehensive Cancer Center
• 1:55-2:10 p.m: Tiffany Carson, Ph.D., Moffitt Cancer Center

Moderator: Charles Rogers, Ph.D., MPH, University of Wisconsin

• 2:30-2:50 p.m: Jasmine McDonald, Ph.D., Columbia University
• 2:50-3:10 p.m: Augusto Ochoa, M.D., Louisiana State University
• 3:10-3:30 p.m: LeeAnn Bailey, Ph.D., NCI Center to Reduce Cancer Health Disparities
• 3:30-3:50 p.m: Kemi Williams, MPH, Astrazeneca

Panel moderated by Henry Henderson, Ph.D., Cancer Awareness, Black in Cancer.

• Emmanuel Perrodin-Njoku, Gallaudet University
• Tshaka Cunningham, Ph.D., Polaris Genomics
• James Lillard, Ph.D., Morehouse School of Medicine

James McCaffrey, CEO, Emerald Foundation

• Ethan Dmitrovsky, M.D., Director, Frederick National Laboratory for Cancer Research
• Iain Foulkes, Executive Director of Research & Innovation, Cancer Research UK